Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 7 of 18
The Effect of Cetirizine HCl on Exercise-induced Arterial Hypoxemia in Highly-trained Swimmers
NCT05095311
ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve -B
NCT06827548
The Reproducibility and Consistency of Instrument-assisted Soft Tissue Manipulation
NCT04923633
TRAIN Your Sleep; Treating Adolescent Insomnia With Cognitive Behavioral Therapy for Insomnia (CBT-I)
NCT04920630
Vascular Effects of Acute Sodium (VEAS) Study
NCT04244604
DEMA-Pro Intervention for Seniors With Subjective Cognitive Decline and Living at Home
NCT04796415
Pharmacokinetics of JULUCA in Hemodialysis
NCT04431518
Bone Health and Microbiome in Persons With Type 1 Diabetes
NCT04784975
Goal Elicitation, Treatment Prioritization, & Electronically-Practiced Discussion for Psychiatry
NCT04601194
Community Solutions to Adolescent Research Consent - Minor Consent for Biomedical HIV Research
NCT05371327
Gabapentin Dosages for Postoperative Analgesia Following Open Thoracotomy
NCT05172570
Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With ADRD
NCT04780178
Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease
NCT04576923
Lactation Cookie Study
NCT04805008
Effects of Subconcussive Head Impacts on Neural Integrity and Function in ADHD
NCT04880304
Renal Considerations in the Heat Stress Recommendations
NCT04767347
County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
NCT04576962
Velacur by Sonic Incytes for Portal Hypertension
NCT04576897
Helping Patients and Providers Make Better Decisions About Colorectal Cancer Screening
NCT04683731
Medications in Breast Milk: A Convenience Pharmacokinetic Study
NCT05099484
Emotion Regulation Intervention to Sustain Physical Activity in Rural-dwelling Women and Men After Myocardial Infarction
NCT04441086
Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation
NCT04683744
HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases
NCT04667702
Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS
NCT04306211
Informational Meetings for Planning and Coordinating Treatment
NCT04330833
Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.
NCT03778411
Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms
NCT04611620
Feasibility and Acceptability of a Chaplain-Led Post-Code Debrief Intervention
NCT04874272
The Combined Effect of Chronic Cannabis Use and Subconcussive Head Impacts on Brain Health
NCT04641832
Remember Stuff: A Dyadic-focused Technology to Support Persons With Alzheimer's Disease in the Community
NCT04626804
The MObile AssessMENT of Behavioral and Psychological Symptoms of Dementia in Amnestic MCI and AD (MOMENT) Study
NCT04482036
Guided Self-help for Common Mental Disorders
NCT04870099
eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
NCT04437485
The Effect of Pretreatment With Roc on Succinylcholine Myalgias
NCT04581395
Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest Wall
NCT04507828
The DECIDE Parent-Provider Intervention
NCT04445155
Reverse King-Devick Test and History of Multiple Concussions
NCT04560400
Collaborative Care for Opioid Dependence And Pain Pilot Study
NCT04121546
Cirrhosis Medical Home
NCT04581369
Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students
NCT04620798
Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment
NCT04400071
Chronic Pain OneSheet Clinical Trial
NCT04295135
Locomotor Recovery Following Traumatic Brain Injury
NCT04503473
Intermittent Hypoxia Paired with High Intensity Training in Brain Injury
NCT04472442
Gene Expression Profiles in Healing and Non-Healing Wounds
NCT01101854
Y90 Radiation Segmentectomy vs SBRT for HCC
NCT04235660
Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis
NCT04072822
Temporal Interference Neurostimulation and Addiction
NCT04432064
COgnitive Intervention to Restore Attention Using Nature Environment
NCT04485507
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
NCT04298853
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.